Nordic Nanovector appoints Dr Gabriele Elbl as Vice President Global Regulatory Affairs
Oslo, Norway, 1 October 2019 Nordic Nanovector ASA (OSE: NANO) announces the appointment of Dr Gabriele Elbl as Vice President Global Regulatory Affairs. Dr Elbl is a pharmacist with more than 20 years’ experience working in small and large pharmaceutical companies and at the European Medicines Agency (EMA). She brings expertise in all regulatory aspects of pharmaceutical development and submission procedures for biologicals and small molecules in Europe and in the US with focus on oncology and haematologic malignancies. Dr Elbl will join Nordic Nanovector on 1 November 2019 from